Recently, additional mutations were identified in ET and PMF wild-type for JAK2 and MPL. We developed a novel molecular assay, based on PNA direct PCR clamping, for a rapid diagnosis of CALR type-1 and 2 mutations in patients affected by MPN. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.